BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32444962)

  • 1. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
    Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
    Cui Y; Zhang C; Wang Y; Ma S; Cao W; Guan F
    Life Sci; 2020 Feb; 243():117230. PubMed ID: 31923422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
    Ye Y; Zhang F; Chen Q; Huang Z; Li M
    Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
    Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
    Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
    Chang S; Liu J; Guo S; He S; Qiu G; Lu J; Wang J; Fan L; Zhao W; Che X
    Oncol Rep; 2016 Jun; 35(6):3577-85. PubMed ID: 27108607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
    Chang Y; Li N; Yuan W; Wang G; Wen J
    Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
    Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
    Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
    Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
    Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
    Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
    Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
    Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
    J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
    Liang F; Liang H; Li Z; Huang P
    Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
    Liang B; Zhao J; Wang X
    PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.